Treatment of acute focal cerebral ischemia with propranolol

Judith A. Capraro, D. Peter Reedy, John P. Latchaw, Robert M. Slugg, Nicholas T. Stowe, Ronald P. Lesser, John R. Little

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Propranolol’s potential as a protective agent against tissue injury has been noted in experimental myocardial, renal and early acute focal cerebral ischemia. The purpose of the present investigat ion was to study further the effects of racemic (d, I) propranolol on blood-brain barrier permeability, morphological changes, cortical electrical activity, and regional cerebral blood flow (rCBF) in experimental focal cerebral ischemia. Thirty adult cats, anesthetized with nitrous oxide, underwent 6 hours of right middle cerebral artery (MCA) occlusion. Fifteen cats were untreated. Fifteen cats were given a continuous infusion of racemic propranolol (1 mg/kg/hr) for 7 hours beginning I hour before MCA occlusion and a 4 mg/kg bolus immediately before occlusion, both directly into the right carotid artery. Right Sylvian rCBF did not significantly differ in the treated and untreated groups. Carbon filling defects and vital dye (i.e., Evans blue and fluorescein) extravasation were less severe in the propranolol treated animals. Light microscopic findings demonstrated no difference in infarct size between the two groups. The findings suggest that at doses given, racemic propranolol does not exert a protective effect upon cerebral t issue subjected to 6 hours of incomplete ischemia.

Original languageEnglish (US)
Pages (from-to)486-491
Number of pages6
Issue number3
StatePublished - Jan 1 1984
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing


Dive into the research topics of 'Treatment of acute focal cerebral ischemia with propranolol'. Together they form a unique fingerprint.

Cite this